LAUSR

1 Theodoridis A, Konstantinidou A, Makrantonaki E, Zouboulis CC. Malignant and benign forms of atrophic papulosis (K€ ohlmeierDegos disease): systemic involvement determines the prognosis. Br J Dermatol 2014; 170: 110–115. 2 Magro CM, Wang X, Garrett-Bakelman F, Laurence J, Shapiro LS, DeSancho MT. The effects of Eculizumab on the pathology of malignant atrophic papulosis. Orphanet J Rare Dis 2013; 26: 185. 3 Wilson J, Walling HW, Stone MS. Benign cutaneous Degos disease in a 16-year-old girl. Pediatr Dermatol 2007; 24: 18–24. 4 Moss C, Wassmer E, Debelle G et al. Degos disease: a new simulator of non-accidental injury. Dev Med Child Neurol 2009; 51: 647–650. 5 Shapiro LS, Toledo-Garcia AE, Farrell JF. Effective treatment of malignant atrophic papulosis (K€ ohlmeier-Degos disease) with treprostinil– early experience. Orphanet J Rare Dis 2013; 4: 52. 6 Katz SK, Mudd LJ, Roenigk HH Jr. Malignant atrophic papulosis (Degos’ disease) involving three generations of a family. J Am Acad Dermatol 1997; 37: 480–484. 7 Toledo AE, Shapiro LS, Farrell JF, Magro CM, Polito J. Laparoscopy shows superiority over endoscopy for early detection of malignant atrophic papulosis gastrointestinal complications: a case report and review of literature. BMC Gastroenterol 2015; 2: 156. 8 Pinault AL, Barbaud A, Weber-Muller F, Schmutz JL. Benign familial Degos disease. Ann Dermatol Venereol 2004; 131: 989–993. 9 Ball E, Newburger A, Ackerman AB. Degos’ disease: a distinctive pattern of disease, chiefly of lupus erythematosus, and not a specific disease per se. Am J Dermatopathol 2003; 25: 308–320. 10 Darwich E, Guilabert A, Mascar o JM Jr et al. Dermoscopic description of a patient with thrombocythemia and factor V Leiden mutation-associated Degos’ disease. Int J Dermatol 2011; 50: 604–606.